Literature DB >> 11166899

Two B cell epitopes of HIV-1 Tat protein have limited antigenic polymorphism in geographically diverse HIV-1 strains.

G Goldstein1, G Tribbick, K Manson.   

Abstract

HIV-1 Tat, a secreted virally encoded toxin, enhances chronic viral replication and induces immune suppression, activities blocked in vitro and in vivo by anti-Tat antibodies. We mapped HIV-1 Tat B cell epitopes, determined sequence variation within them in 350 Tat sequences in GenBank, and determined antigenic cross-reactions between significant amino acid polymorphs. Two of the four B cell epitope sequences identified had limited or no antigenic polymorphism within geographically diverse strains. For epitope 1 in primates, (V,I)4DP(R,K,S,N)7L(E,D)9PW(N,K)12, the most frequent antigenic polymorphs were VDPRLEPWK in B clades (75%) and VDPNLEPWN in non-B clades (64%), with five additional sequences occurring at lower incidence. Epitope 2 in primates, K41(G,A)42LGISYGRK50, had no antigenic polymorphism. These two epitopes have potential utility for the generation of universal vaccine immunogens and therapeutic antibodies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166899     DOI: 10.1016/s0264-410x(00)00393-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Tat-neutralizing antibodies in vaccinated macaques.

Authors:  Ilia Tikhonov; Tracy J Ruckwardt; Glen S Hatfield; C David Pauza
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Generation and characterization of neutralizing human monoclonal antibodies against human immunodeficiency virus type 1 Tat antigen.

Authors:  Emmanuel Moreau; Johan Hoebeke; Daniel Zagury; Sylviane Muller; Claude Desgranges
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

3.  Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking.

Authors:  Raffaella Pierleoni; Michele Menotta; Antonella Antonelli; Carla Sfara; Giordano Serafini; Sabrina Dominici; Maria Elena Laguardia; Annalisa Salis; Gianluca Damonte; Lucia Banci; Marco Porcu; Paolo Monini; Barbara Ensoli; Mauro Magnani
Journal:  Mol Cell Biochem       Date:  2010-08-20       Impact factor: 3.396

4.  Impaired plant growth and development caused by human immunodeficiency virus type 1 Tat.

Authors:  Marni E Cueno; Yurina Hibi; Kenichi Imai; Antonio C Laurena; Takashi Okamoto
Journal:  Transgenic Res       Date:  2010-01-20       Impact factor: 2.788

5.  Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein.

Authors:  Peter Silvera; Max W Richardson; Jack Greenhouse; Jake Yalley-Ogunro; Nigel Shaw; Jyotika Mirchandani; Kamel Khalili; Jean-Francois Zagury; Mark G Lewis; Jay Rappaport
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Novel biopanning strategy to identify epitopes associated with vaccine protection.

Authors:  Barbara C Bachler; Michael Humbert; Brisa Palikuqi; Nagadenahalli B Siddappa; Samir K Lakhashe; Robert A Rasmussen; Ruth M Ruprecht
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

7.  HIV-1 Tat B-cell epitope vaccination was ineffectual in preventing viral rebound after ART cessation: HIV rebound with current ART appears to be due to infection with new endogenous founder virus and not to resurgence of pre-existing Tat-dependent viremia.

Authors:  Gideon Goldstein; Eve Damiano; Mardik Donikyan; Malika Pasha; Erik Beckwith; John Chicca
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

8.  Fruit-specific expression of the human immunodeficiency virus type 1 tat gene in tomato plants and its immunogenic potential in mice.

Authors:  Yuri Jorge Peña Ramírez; Ennio Tasciotti; Abel Gutierrez-Ortega; Alberto J Donayre Torres; María Teresa Olivera Flores; Mauro Giacca; Miguel Angel Gómez Lim
Journal:  Clin Vaccine Immunol       Date:  2007-04-25

9.  Preferential expression and immunogenicity of HIV-1 Tat fusion protein expressed in tomato plant.

Authors:  Marni E Cueno; Yurina Hibi; Katsuo Karamatsu; Yasuhiro Yasutomi; Kenichi Imai; Antonio C Laurena; Takashi Okamoto
Journal:  Transgenic Res       Date:  2010-01-14       Impact factor: 2.788

10.  Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.

Authors:  Lakshmi Ramakrishna; Krishnamurthy Kumar Anand; Kumarasamypet M Mohankumar; Udaykumar Ranga
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.